Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,300 | 3 | 81.9% |
| Travel and Lodging | $925.81 | 3 | 9.1% |
| Food and Beverage | $914.47 | 14 | 9.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $6,952 | 15 | $0 (2024) |
| Theratechnologies Inc. | $3,142 | 2 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $29.03 | 2 | $0 (2021) |
| ViiV Healthcare Company | $16.58 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,919 | 8 | Theratechnologies Inc. ($3,142) |
| 2023 | $72.01 | 1 | Gilead Sciences, Inc. ($72.01) |
| 2022 | $5,104 | 8 | Gilead Sciences, Inc. ($5,104) |
| 2021 | $24.90 | 1 | Merck Sharp & Dohme Corporation ($24.90) |
| 2020 | $4.13 | 1 | Merck Sharp & Dohme Corporation ($4.13) |
| 2017 | $16.58 | 1 | ViiV Healthcare Company ($16.58) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,390.00 | General |
| 11/01/2024 | Theratechnologies Inc. | TROGARZO (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: HIV | ||||||
| 10/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $149.84 | General |
| 10/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $144.18 | General |
| 10/11/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $142.43 | General |
| Category: HIV | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.00 | General |
| 06/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.41 | General |
| 03/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $40.95 | General |
| 05/05/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $72.01 | General |
| 12/20/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Consulting Fee | Cash or cash equivalent | $3,910.00 | General |
| Category: HIV | ||||||
| 12/09/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $49.84 | General |
| Category: HIV | ||||||
| 12/09/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $49.84 | General |
| Category: HIV | ||||||
| 12/09/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $48.49 | General |
| Category: HIV | ||||||
| 12/08/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Travel and Lodging | In-kind items and services | $425.19 | General |
| Category: HIV | ||||||
| 12/08/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Travel and Lodging | In-kind items and services | $300.00 | General |
| Category: HIV | ||||||
| 12/08/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Travel and Lodging | In-kind items and services | $200.62 | General |
| Category: HIV | ||||||
| 12/08/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $119.87 | General |
| Category: HIV | ||||||
| 07/28/2021 | Merck Sharp & Dohme Corporation | DELSTRIGO (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/28/2020 | Merck Sharp & Dohme Corporation | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/31/2017 | ViiV Healthcare Company | TRIUMEQ (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 19 | 35 | $5,001 | $1,498 |
| 2022 | 1 | 19 | 36 | $4,975 | $1,644 |
| 2021 | 2 | 36 | 54 | $8,910 | $3,380 |
| 2020 | 2 | 22 | 33 | $6,765 | $2,225 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 35 | $5,001 | $1,498 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 36 | $4,975 | $1,644 | 33.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 39 | $6,145 | $2,256 | 36.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 15 | $2,765 | $1,124 | 40.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 22 | $5,120 | $1,633 | 31.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $1,645 | $592.49 | 36.0% |
About Dr. Michelle Collins-Ogle, M.D
Dr. Michelle Collins-Ogle, M.D is a Specialist healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336275403.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Collins-Ogle, M.D has received a total of $10,140 in payments from pharmaceutical and medical device companies, with $4,919 received in 2024. These payments were reported across 20 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($8,300).
As a Medicare-enrolled provider, Collins-Ogle has provided services to 96 Medicare beneficiaries, totaling 158 services with total Medicare billing of $8,747. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Pediatrics, Adolescent Medicine
- Location Bronx, NY
- Active Since 02/25/2007
- Last Updated 10/21/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336275403
Products in Payments
- Descovy (Drug) $5,104
- TROGARZO (Drug) $3,000
- EGRIFTA (Drug) $142.43
- DELSTRIGO (Drug) $24.90
- TRIUMEQ (Drug) $16.58
- PIFELTRO (Drug) $4.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Bronx
Randall Berliner, Md, MD
Specialist — Payments: $203,928
Mahmood Kazmi
Specialist — Payments: $186,504
Dr. Peter Barland, M.d, M.D
Specialist — Payments: $85,232
Dr. Evan Garfein, Md, MD
Specialist — Payments: $75,467
Dr. Ghazanfar Abdullah, Md, MD
Specialist — Payments: $42,101
Karen Hennessey, M.d, M.D
Specialist — Payments: $30,727